tiprankstipranks
Trending News
More News >

Amgen reports Q1 adjusted EPS $4.90, consensus $4.26

Reports Q1 revenue $8.1B, consensus $8.04B. “Demand for our products was strong globally in the first quarter. Ongoing new product launches and successful Phase 3 trial results for several products make us feel confident in our long-term growth prospects,” said Robert A. Bradway, chairman and chief executive officer.

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>

Disclaimer & DisclosureReport an Issue